Lopinavir Recruiting Phase 2 / 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19
https://clinicaltrials.gov/ct2/show/FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals